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models of nociception in mice 
 
Abstract 
The present study examined the potential antinociceptive activity of flavokawin B (6'-
hydroxy-2',4'-dimethoxychalcone), a synthetic chalcone using chemical- and thermal-induced 
nociception models in mice. It was demonstrated that flavokawin B (FKB; 0.3, 1, 3 and 10 
mg/kg) administered via both oral (p.o.) and intraperitoneal (i.p.) routes produced significant 
and dose-dependent inhibition in the abdominal constrictions induced by acetic acid, with the 
i.p. route producing antinociception of approximately 7-fold more potent than the p.o. route. 
It was also demonstrated that FKB produced significant inhibition in the two phases of the 
formalin-induced paw licking test. In addition, the same treatment of flavokawin B (FKB) 
exhibited significant inhibition of the neurogenic nociceptive induced by intraplantar 
injections of glutamate and capsaicin. Likewise, this compound also induced a significant 
increase in the response latency period to thermal stimuli in the hot plate test and its 
antinociceptive effect was not related to muscle relaxant or sedative action. Moreover, the 
antinociception effect of the FKB in the formalin-induced paw licking test and the hot plate 
test was not affected by pretreatment of non-selective opioid receptor antagonist, naloxone. 
The present results indicate that FKB produced pronounced antinociception effect against 
both chemical and thermal models of pain in mice that exhibited both peripheral and central 
analgesic activity. 
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